Thermo Fisher Scientific introduces CorEvitas Pharmacovigilance Platform
The primary application of CorEvidence focuses on improving pharmacovigilance workflows and managing deliverables more effectively
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Dec 23
The primary application of CorEvidence focuses on improving pharmacovigilance workflows and managing deliverables more effectively
20 Dec 23
Qelbree is a commercially available prescription medication in the US to treat ADHD and Supernus has granted Knight…
20 Dec 23
COM503 is a potential first-in-class, high affinity antibody that inhibits the progression of cancer by releasing endogenous IL-18…
19 Dec 23
Otsuka will acquire exclusive rights to market donidalorsen in Europe in exchange for an upfront payment of $65m,…
19 Dec 23
Manufactured from pooled human plasma from American donors, Alyglo is a liquid solution with 10% immunoglobulin G (100…
19 Dec 23
The late-stage trial assessed the combination against placebo plus chemotherapy followed by placebo and the combination met the…
19 Dec 23
Under the terms of the agreement, Biocytogen will provide Ona with the opportunity to assess Biocytogen's proprietary fully…
19 Dec 23
Under the terms of the agreement, Lilly will remain the marketing authorisation holder and will produce migraine drugs…
19 Dec 23
Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a…
18 Dec 23
The approval was based on the findings from the Phase 3 EV-302 in which the combination nearly doubled…